TY - JOUR
T1 - A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat
AU - Porreca, Frank
AU - Raffa, Robert B.
AU - Cowan, Alan
AU - Tallarida, Ronald J.
PY - 1982/11/1
Y1 - 1982/11/1
N2 - The efficacies and dissociation constants of proposed mu and kappa receptor agonists (morphine and ethylketocyclazocine, respectively) were compared using the method of partial irreversible blockade (with buprenorphine) and Stephenson's theory of drug action. While there was good agreement between the dissociation constant (KA) of morphine in analgesia (3.3 × 10-5 M) and in inhibition of gastrointestinal transit (1.1 × 10-5 M), the KA of ethylketocyclazocine differed by an order of magnitude in these endpoints (3.2 × 10-6 M and 6.7 × 10-5 M, respectively). The efficacies of morphine were found to be similar for the two effects studied (4.23 and 5.26), while those for ethylketocyclazocine differed markedly (2.06 and 10.39). The fraction of receptors remaining unblocked after buprenorphine was consistent for the test but not for the agonist, indicating a different distribution of receptors for the two endpoints. Our results strongly suggest that morphine induces analgesia, and slows transit in the small intestine, through the same type of receptor. The same conclusion cannot be drawn for ethylketocyclazocine.
AB - The efficacies and dissociation constants of proposed mu and kappa receptor agonists (morphine and ethylketocyclazocine, respectively) were compared using the method of partial irreversible blockade (with buprenorphine) and Stephenson's theory of drug action. While there was good agreement between the dissociation constant (KA) of morphine in analgesia (3.3 × 10-5 M) and in inhibition of gastrointestinal transit (1.1 × 10-5 M), the KA of ethylketocyclazocine differed by an order of magnitude in these endpoints (3.2 × 10-6 M and 6.7 × 10-5 M, respectively). The efficacies of morphine were found to be similar for the two effects studied (4.23 and 5.26), while those for ethylketocyclazocine differed markedly (2.06 and 10.39). The fraction of receptors remaining unblocked after buprenorphine was consistent for the test but not for the agonist, indicating a different distribution of receptors for the two endpoints. Our results strongly suggest that morphine induces analgesia, and slows transit in the small intestine, through the same type of receptor. The same conclusion cannot be drawn for ethylketocyclazocine.
UR - http://www.scopus.com/inward/record.url?scp=0020353221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020353221&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(82)90034-0
DO - 10.1016/0024-3205(82)90034-0
M3 - Article
C2 - 6294424
AN - SCOPUS:0020353221
SN - 0024-3205
VL - 31
SP - 1955
EP - 1961
JO - Life Sciences
JF - Life Sciences
IS - 18
ER -